The stock of BioNexus Gene Lab Corp (NASDAQ: BGLC) has increased by 21.20 when compared to last closing price of 2.17. Despite this, the company
The stock has a 36-month beta value of 1.63. The public float for BGLC is 11.03M, and at present, short sellers hold a 2.12% of
In the past week, BGLC stock has gone down by -12.25%, with a monthly decline of -25.37% and a quarterly surge of 2.92%. The volatility
BioNexus Gene Lab Corp (NASDAQ: BGLC)’s stock price has increased by 12.80 compared to its previous closing price of 0.28. However, the company has seen
© 2024, Powered by Smart TechOne
